Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a …
…, M Goyal, AM Demchuk, BK Menon, M Eesa - The Lancet …, 2019 - thelancet.com
Background CT perfusion (CTP) and diffusion or perfusion MRI might assist patient selection
for endovascular thrombectomy. We aimed to establish whether imaging assessments of …
for endovascular thrombectomy. We aimed to establish whether imaging assessments of …
[HTML][HTML] Randomized assessment of rapid endovascular treatment of ischemic stroke
Background Among patients with a proximal vessel occlusion in the anterior circulation, 60
to 80% of patients die within 90 days after stroke onset or do not regain functional …
to 80% of patients die within 90 days after stroke onset or do not regain functional …
Toxic and acquired metabolic encephalopathies: MRI appearance
P Sharma, M Eesa, JN Scott - American Journal of …, 2009 - Am Roentgen Ray Soc
OBJECTIVE. The differential diagnosis of patients presenting with acute encephalopathy is
broad. Imaging can help in narrowing the differential in many cases. We pictorially review the …
broad. Imaging can help in narrowing the differential in many cases. We pictorially review the …
Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke
Endovascular therapy (EVT) for acute ischemic stroke in selected patients has recently been
proven effective in several clinical trials, and the widespread adoption of thrombectomy into …
proven effective in several clinical trials, and the widespread adoption of thrombectomy into …
Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial
Background Nerinetide, an eicosapeptide that interferes with post-synaptic density protein
95, is a neuroprotectant that is effective in preclinical stroke models of ischaemia-reperfusion. …
95, is a neuroprotectant that is effective in preclinical stroke models of ischaemia-reperfusion. …
Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a …
…, M Goyal, AM Demchuk, BK Menon, M Eesa… - The Lancet …, 2018 - thelancet.com
Background General anaesthesia (GA) during endovascular thrombectomy has been
associated with worse patient outcomes in observational studies compared with patients treated …
associated with worse patient outcomes in observational studies compared with patients treated …
Analysis of workflow and time to treatment on thrombectomy outcome in the endovascular treatment for small core and proximal occlusion ischemic stroke (ESCAPE) …
…, J Teitelbaum, C Lum, D Dowlatshahi, M Eesa… - Circulation, 2016 - Am Heart Assoc
Background— The Endovascular Treatment for Small Core and Proximal Occlusion Ischemic
Stroke (ESCAPE) trial used innovative imaging and aggressive target time metrics to …
Stroke (ESCAPE) trial used innovative imaging and aggressive target time metrics to …
Association of clinical, imaging, and thrombus characteristics with recanalization of visible intracranial occlusion in patients with acute ischemic stroke
Importance Recanalization of intracranial thrombus is associated with improved clinical
outcome in patients with acute ischemic stroke. The association of intravenous alteplase …
outcome in patients with acute ischemic stroke. The association of intravenous alteplase …
CTA collateral status and response to recanalization in patients with acute ischemic stroke
BACKGROUND AND PURPOSE: Collateral status at baseline is an independent determinant
of clinical outcome among patients with acute ischemic stroke. We sought to identify …
of clinical outcome among patients with acute ischemic stroke. We sought to identify …
Endovascular treatment for Small Core and Anterior circulation Proximal occlusion with Emphasis on minimizing CT to recanalization times (ESCAPE) trial …
ESCAPE is a prospective, multicenter, randomized clinical trial that will enroll subjects with
the following main inclusion criteria: less than 12 h from symptom onset, age > 18, baseline …
the following main inclusion criteria: less than 12 h from symptom onset, age > 18, baseline …
